Optimal duration of anticoagulation in patients with venous thromboembolism

The risk of recurrent venous thromboembolism (VTE) approaches 40 per cent of all patients after 10 yr of follow up. This risk is higher in patients with permanent risk factors of thrombosis such as active cancer, prolonged immobilization from medical diseases, and antiphospholipid syndrome; in carri...

Descripción completa

Detalles Bibliográficos
Autores principales: Prandoni, Paolo, Piovella, Chiara, Spiezia, Luca, Valle, Fabio Dalla, Pesavento, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171911/
https://www.ncbi.nlm.nih.gov/pubmed/21808129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171911/
https://www.ncbi.nlm.nih.gov/pubmed/21808129

Ejemplares similares